Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

(BHVN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Mixed Premarket Wednesday

07/07/2021 | 09:10am EDT


ę MT Newswires 2021
All news about BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
09/13BIOHAVEN PHARMACEUTICAL : Cantor Fitzgerald Adjusts Biohaven Pharmaceutical Holding's Pric..
MT
09/10BIOHAVEN PHARMACEUTICAL : Spotlights nurtec odt (rimegepant), the only dual-therapy indica..
AQ
09/09BIOHAVEN PHARMACEUTICAL : Spotlights Nurtec« ODT (rimegepant), the only dual-therapy indic..
PR
08/10BIOHAVEN PHARMACEUTICAL : UBS Downgrades Biohaven Pharmaceutical to Neutral From Buy on Va..
MT
08/10BIOHAVEN PHARMACEUTICAL : Wedbush Adjusts Biohaven Pharmaceutical's Price Target to $128 F..
MT
08/09BIOHAVEN PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and ..
AQ
08/09BIOHAVEN PHARMACEUTICAL HOLDING CO L : Results of Operations and Financial Condition, Fina..
AQ
08/09BIOHAVEN PHARMACEUTICAL : Posts Wider Q2 Loss
MT
08/09BIOHAVEN PHARMACEUTICAL : Earnings Flash (BHVN) BIOHAVEN PHARMACEUTICAL HOLDING COMPANY Po..
MT
08/09BIOHAVEN PHARMACEUTICAL : Reports Second Quarter 2021 Financial Results And Recent Busines..
PR
More news
Analyst Recommendations on BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
More recommendations
Financials (USD)
Sales 2021 378 M - -
Net income 2021 -803 M - -
Net Debt 2021 388 M - -
P/E ratio 2021 -10,5x
Yield 2021 -
Capitalization 8 670 M 8 670 M -
EV / Sales 2021 24,0x
EV / Sales 2022 12,7x
Nbr of Employees 825
Free-Float 86,0%
Chart BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Duration : Period :
Biohaven Pharmaceutical Holding Company Ltd. Technical Analysis Chart | BHVN | VGG111961055 | MarketScreener
Technical analysis trends BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 132,57 $
Average target price 135,64 $
Spread / Average Target 2,31%
EPS Revisions
Managers and Directors
Vladimir Coric Chief Executive Officer & Director
James Engelhart Chief Financial Officer & Treasurer
Declan Doogan Independent Chairman
Charles Conway Chief Scientific Officer
Elyse Stock Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.54.67%8 670
MODERNA, INC.305.22%170 876
LONZA GROUP AG31.58%59 927
IQVIA HOLDINGS INC.41.30%48 510
CELLTRION, INC.-23.26%31 691
SEAGEN INC.-9.18%28 939